Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
Takeda K, Kawasaki Y, Sakayauchi T, Takahashi C, Katagiri Y, Tanabe T, Ishikawa Y, Fujimoto K, Kubozono M, Kozumi M, Abe K, Narazaki K, Tasaka S, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Ito A, Jingu K. Takeda K, et al. Among authors: omata s. Asia Ocean J Nucl Med Biol. 2023;11(1):13-22. doi: 10.22038/AOJNMB.2022.67136.1468. Asia Ocean J Nucl Med Biol. 2023. PMID: 36619192 Free PMC article.
Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study.
Yamamoto T, Katagiri Y, Tsukita Y, Matsushita H, Umezawa R, Katsuta Y, Kadoya N, Takahashi N, Suzuki Y, Takeda K, Kishida K, Omata S, Miyauchi E, Saito R, Jingu K. Yamamoto T, et al. Among authors: omata s. Cancers (Basel). 2022 Aug 18;14(16):3993. doi: 10.3390/cancers14163993. Cancers (Basel). 2022. PMID: 36010985 Free PMC article.
Longitudinal analyses and predictive factors of radiation-induced lung toxicity-related parameters after stereotactic radiotherapy for lung cancer.
Yamamoto T, Katsuta Y, Sato K, Tsukita Y, Umezawa R, Takahashi N, Suzuki Y, Takeda K, Kishida K, Omata S, Miyauchi E, Saito R, Kadoya N, Jingu K. Yamamoto T, et al. Among authors: omata s. PLoS One. 2022 Dec 2;17(12):e0278707. doi: 10.1371/journal.pone.0278707. eCollection 2022. PLoS One. 2022. PMID: 36459528 Free PMC article.
Clinical impact of multimodal treatment including chemoradiotherapy, conversion surgery and postoperative chemotherapy for borderline resectable and unresectable locally advanced pancreatic cancer without disease progression after gemcitabine plus nab-paclitaxel.
Umezawa R, Mizuma M, Nakagawa K, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Unno M, Jingu K. Umezawa R, et al. Among authors: omata s. Pancreatology. 2023 Sep;23(6):650-656. doi: 10.1016/j.pan.2023.07.002. Epub 2023 Jul 4. Pancreatology. 2023. PMID: 37453848 Free article.
Glasgow prognostic score for assessing the efficacy of whole-brain radiation therapy in cases of recursive partitioning analysis class 2 and class 3 multiple brain metastases: a retrospective study.
Ishikawa Y, Umezawa R, Yamamoto T, Takahashi N, Takeda K, Suzuki Y, Kishida K, Omata S, Teramura S, Ito K, Yamada T, Jingu K. Ishikawa Y, et al. Among authors: omata s. Acta Neurol Belg. 2024 Feb;124(1):231-239. doi: 10.1007/s13760-023-02384-x. Epub 2023 Sep 25. Acta Neurol Belg. 2024. PMID: 37747688 Free PMC article.
170 results